Bioprocess containers Market by Type (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories), Application (Upstream Process, Downstream Process, and Process Development), End user (Biopharmaceutical Companies, Life Science R&D Companies, and Academic & Research Institutes): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026442 | Pages: 100 | Industry: Medical Device | Date: Sep 2022 | Type: Global

The market crossed US$ 3.5 billion mark in 2022 and is expected to hit US$ 12.0 billion by 2030, recording a CAGR of 26.0% during the forecast period.

The bioprocess containers market has been significantly growing due to the increasing demand for biologics.

There is an increasing case of cancer, diabetes, and another chronic disease globally which led to the development of vaccines and medicines. This growing disease condition and increasing biologics drive the global bioprocess containers market. The 2D bioprocess containers segment is expected to pace up as it is frequently used for cell harvesting and transportation of bulk drug products. Thus, the 2D bioprocess segments are expected to gain traction during the forecasted year.

Within the report, the market is segmented into type, application, end user, and geography. By type, the market is further segmented into 2D bioprocess containers, 3D bioprocess containers, and other containers & accessories. On the basis of application, the market is segmented into upstream processes, downstream processes, and process development. By end user, the market is categorized into biopharmaceuticals companies, life science R&D companies, and academics & research institutes. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

The bioprocess containers market is growing due to many patent expiry of biologics.

The patent expiry of many drugs led to increased R&D spending by many companies. This has led to increased R&D of many biologics from pipeline to commercial production. The companies are focusing on more economical processes than traditional biomanufacturing methods. Bioprocess containers are available at affordable prices which satisfies the customer’s needs and demands. Thus, these factors are expected to boost the growth of the market.

 

Growing pharmaceuticals & biopharmaceuticals companies is one of the major factors accelerating the market growth.

The growing senior citizen’s population globally led to the development of many biologics which in turn promotes the growth of pharmaceuticals & biopharmaceuticals companies. Further, the bioprocess containers have wider applications in the research & process development which increase the growth of biologics and biosimilar which in turn promote the growth of the bioprocess containers market.

 

Recent strategic developments in the bioprocess containers market

The bioprocess containers market has undergone several significant developments, and a few of these have been mentioned below:

  • In September 2021, Avantor acquired RIM Bio, located in China, is a manufacturer of single-use bioprocess bags and assembles for biopharmaceutical applications. This acquisition has helped the company to expand its bioproduction in China.
  • In March 2021, Merck KGaA, Germany, invested approximately USD 30 million at its Life Science Center in Molsheim to add a single-use technology production unit to produce COVID-19 vaccines and other therapies.
  • In December 2020, the company has planned to increase its manufacturing capacity of 2D and 3D bioprocessing container chambers by 70% by expanding its Utah bioprocess container site by adding 20,000 square feet of room space.

 

The bioprocess containers market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Thermo Fisher Scientific Inc., Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Danaher Corporation, Merck Millipore, Sartorius Stedim Biotech, Fluidscontrol, Rim Bio, Fenner, Meissner are among the prominent players operating in the market.

Target audience for the report:

  • Biopharmaceuticals companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Biotechnology  companies

Scope of the report:

In this report, the market has been segmented on the basis of:

Type (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories), Application (Upstream Process, Downstream Process, and Process Development), End user (Biopharmaceutical Companies, Life Science R&D Companies, and Academic & Research Institutes):

  • Type:
    • 2D Bioprocess Containers
    • 3D Bioprocess Containers
    • Other Containers & Accessories

 

  • Application
    • Upstream Process
    • Downstream Process
    • Process Development
  • End User
    • Biopharmaceutical companies
    • Life Sciences R&D companies
    • Academic & Research Institutes

 

  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Thermo Fisher Scientific Inc.,
    • Saint-Gobain S.A.,
    • Lonza Group AG, Avantor Inc.,
    • Danaher Corporation,
    • Merck Millipore,
    • Sartorius Stedim Biotech
    • Fluidscontrol
    • Rim Bio
    • Fenner
    • Meissner

Companies profiled
- Thermo Fisher Scientific Inc.,
- Saint-Gobain S.A.,
- Lonza Group AG, Avantor Inc.,
- Danaher Corporation,
- Merck Millipore,
- Sartorius Stedim Biotech
- Fluidscontrol
- Rim Bio
- Fenner
- Meissner


Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000